Work

Classification system proposed to guide the design, development, regulatory approval, and scaling of long acting, small- and macro-molecule parenteral products (CS-BLAP)

Year: 2025

Type: review

Source: Journal of Pharmaceutical Sciences

DOI: 10.1016/j.xphs.2025.104056

Authors: Simone Perazzolo, Danny D. Shen, Rodney J.Y. Ho

Institution: University of Washington

Language: English

Topic: Advanced Drug Delivery Systems

Subfield: Pharmaceutical Science

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, World Health Organization Centre for Health Development, National Heart, Lung, and Blood Institute, National Institute of Allergy and Infectious Diseases, Office of AIDS Research, Unitaid

Awards: Targeted Long-acting Combination Antiretroviral Therapy (TLC-ART), G42804487, G5547925133, Washington Entrepreneurial Research Evaluation and Commercialization Hub, "NextGen Long-acting Platform: Targeted Combination Antiretrovirals", NextGen Long-acting and targeted combination ART for Children with HIV, Long-acting Antiviral Treatment for HBV, G9000094890, NextGen Long-acting and targeted combination ART for Children with HIV, G972604516

OpenAlex ID: W4415951493

FWCI: 0.206

Cites: 68

Cited by: 3

Related to: 10